Nutraceutical strategies for ameliorating the toxic effects of alcohol

Medical Hypotheses

Volumn 80, Issue 4, 2013, Pages 456-462

  McCarty, Mark F ^a  

^a NutriGuard Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETALDEHYDE; ACETYLCYSTEINE; ALCOHOL; ALDEHYDE DEHYDROGENASE; ASTAXANTHIN; MELATONIN; NUTRACEUTICAL; PANTETHINE; PHYCOCYANOBILIN; TAURINE; THIOCTIC ACID; UNCLASSIFIED DRUG;

ALCOHOL CONSUMPTION; ALCOHOL INTOXICATION; ARTICLE; ENZYME ACTIVITY; HUMAN; NONHUMAN; OXIDATIVE STRESS; RISK BENEFIT ANALYSIS;

ALCOHOL-RELATED DISORDERS; ANTIOXIDANTS; DIETARY SUPPLEMENTS; HUMANS; MODELS, BIOLOGICAL; REACTIVE OXYGEN SPECIES;

RODENTIA; SPIRULINA;

EID: 84875406983     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.12.040     Document Type: Article

References (157)

1. Das S.K., Vasudevan D.M. Alcohol-induced oxidative stress. Life Sci 2007 June 27, 81(3):177-187.
2. Wu D., Zhai Q., Shi X. Alcohol-induced oxidative stress and cell responses. J Gastroenterol Hepatol 2006, 21(Suppl. 3):S26-S29.
3. Cederbaum A.I., Lu Y., Wu D. Role of oxidative stress in alcohol-induced liver injury. Arch Toxicol 2009, 83(6):519-548.
4. Zhang X., Li S.Y., Brown R.A., Ren J. Ethanol and acetaldehyde in alcoholic cardiomyopathy: from bad to ugly en route to oxidative stress. Alcohol 2004, 32(3):175-186.
5. Brocardo P.S., Gil-Mohapel J., Christie B.R. The role of oxidative stress in fetal alcohol spectrum disorders. Brain Res Rev 2011, 67(1-2):209-225.
6. Eriksson C.J. The role of acetaldehyde in the actions of alcohol. Alcohol Clin Exp Res 2001, 25(Suppl. 5 ISBRA):15S-32S. (update 2000).
7. Mello T., Ceni E., Surrenti C., Galli A. Alcohol induced hepatic fibrosis: role of acetaldehyde. Mol Aspects Med 2008, 29(1-2):17-21.
8. Zhang Y., Ren J. ALDH2 in alcoholic heart diseases: molecular mechanism and clinical implications. Pharmacol Ther 2011, 132(1):86-95.
9. Seitz H.K., Becker P. Alcohol metabolism and cancer risk. Alcohol Res Health 2007, 30(1):38-47.
10. Brooks P.J., Theruvathu J.A. DNA adducts from acetaldehyde: implications for alcohol-related carcinogenesis. Alcohol 2005, 35(3):187-193.
11. Lieber C.S. Role of oxidative stress and antioxidant therapy in alcoholic and nonalcoholic liver diseases. Adv Pharmacol 1997, 38:601-628.
12. Comporti M., Signorini C., Leoncini S., Gardi C., Ciccoli L., Giardini A., et al. Ethanol-induced oxidative stress: basic knowledge. Genes Nutr 2010, 5(2):101-109.
13. Kono H., Rusyn I., Yin M., Gabele E., Yamashina S., Dikalova A., et al. NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. J Clin Invest 2000, 106(7):867-872.
14. Kono H., Rusyn I., Uesugi T., Yamashina S., Connor H.D., Dikalova A., et al. Diphenyleneiodonium sulfate, an NADPH oxidase inhibitor, prevents early alcohol-induced liver injury in the rat. Am J Physiol Gastrointest Liver Physiol 2001, 280(5):G1005-G1012.
15. Wheeler M.D., Kono H., Yin M., Nakagami M., Uesugi T., Arteel G.E., et al. The role of Kupffer cell oxidant production in early ethanol-induced liver disease. Free Radic Biol Med 2001, 31(12):1544-1549.
16. Yamashina S., Takei Y., Ikejima K., Enomoto N., Kitamura T., Sato N. Ethanol-induced sensitization to endotoxin in Kupffer cells is dependent upon oxidative stress. Alcohol Clin Exp Res 2005, 29(Suppl. 12):246S-250S.
17. Thakur V., Pritchard M.T., McMullen M.R., Wang Q., Nagy L.E. Chronic ethanol feeding increases activation of NADPH oxidase by lipopolysaccharide in rat Kupffer cells: role of increased reactive oxygen in LPS-stimulated ERK1/2 activation and TNF-alpha production. J Leukoc Biol 2006, 79(6):1348-1356.
18. Hu R., Wang Y.L., Edderkaoui M., Lugea A., Apte M.V., Pandol S.J. Ethanol augments PDGF-induced NADPH oxidase activity and proliferation in rat pancreatic stellate cells. Pancreatology 2007, 7(4):332-340.
19. Cohen A.C., Tong M., Wands J.R., de la Monte S.M. Insulin and insulin-like growth factor resistance with neurodegeneration in an adult chronic ethanol exposure model. Alcohol Clin Exp Res 2007, 31(9):1558-1573.
20. De M.S., Brenner D.A. Oxidative stress in alcoholic liver disease: role of NADPH oxidase complex. J Gastroenterol Hepatol 2008, 23(Suppl 1):S98-103.
21. Dong J., Sulik K.K., Chen S.Y. The role of NOX enzymes in ethanol-induced oxidative stress and apoptosis in mouse embryos. Toxicol Lett 2010, 193(1):94-100.
22. Choudhury M., Park P.H., Jackson D., Shukla S.D. Evidence for the role of oxidative stress in the acetylation of histone H3 by ethanol in rat hepatocytes. Alcohol 2010, 44(6):531-540.
23. Chen J.R., Lazarenko O.P., Shankar K., Blackburn M.L., Lumpkin C.K., Badger T.M., et al. Inhibition of NADPH oxidases prevents chronic ethanol-induced bone loss in female rats. J Pharmacol Exp Ther 2011, 336(3):734-742.
24. Hasegawa T., Kikuyama M., Sakurai K., Kambayashi Y., Adachi M., Saniabadi A.R., et al. Mechanism of superoxide anion production by hepatic sinusoidal endothelial cells and Kupffer cells during short-term ethanol perfusion in the rat. Liver 2002, 22(4):321-329.
25. Polikandriotis J.A., Rupnow H.L., Elms S.C., Clempus R.E., Campbell D.J., Sutliff R.L., et al. Chronic ethanol ingestion increases superoxide production and NADPH oxidase expression in the lung. Am J Respir Cell Mol Biol 2006, 34(3):314-319.
26. Husain K. Vascular endothelial oxidative stress in alcohol-induced hypertension. Cell Mol Biol (Noisy-le-grand) 2007, 53(1):70-87.
27. Husain K., Ferder L., Ansari R.A., Lalla J. Chronic ethanol ingestion induces aortic inflammation/oxidative endothelial injury and hypertension in rats. Hum Exp Toxicol 2010.
28. Rump T.J., Bdul Muneer P.M., Szlachetka A.M., Lamb A., Haorei C., Alikunju S., et al. Acetyl-l-carnitine protects neuronal function from alcohol-induced oxidative damage in the brain. Free Radic Biol Med 2010, 49(10):1494-1504.
29. Sun H., Molacek E., Zheng H., Fang Q., Patel K.P., Mayhan W.G. Alcohol-induced impairment of neuronal nitric oxide synthase (nNOS)-dependent dilation of cerebral arterioles: role of NAD(P)H oxidase. J Mol Cell Cardiol 2006, 40(2):321-328.
30. Sun H., Zheng H., Molacek E., Fang Q., Patel K.P., Mayhan W.G. Role of NAD(P)H oxidase in alcohol-induced impairment of endothelial nitric oxide synthase-dependent dilation of cerebral arterioles. Stroke 2006, 37(2):495-500.
31. Zhao H., Mayhan W.G., Arrick D.M., Xiong W., Sun H. Alcohol-induced exacerbation of ischemic brain injury: role of NAD(P)H oxidase. Alcohol Clin Exp Res 2010, 34(11):1948-1955.
32. Haorah J., Ramirez S.H., Floreani N., Gorantla S., Morsey B., Persidsky Y. Mechanism of alcohol-induced oxidative stress and neuronal injury. Free Radic Biol Med 2008, 45(11):1542-1550.
33. Doser T.A., Turdi S., Thomas D.P., Epstein P.N., Li S.Y., Ren J. Transgenic overexpression of aldehyde dehydrogenase-2 rescues chronic alcohol intake-induced myocardial hypertrophy and contractile dysfunction. Circulation 2009, 119(14):1941-1949.
34. Alikunju S., Bdul Muneer P.M., Zhang Y., Szlachetka A.M., Haorah J. The inflammatory footprints of alcohol-induced oxidative damage in neurovascular components. Brain Behav Immun 2011.
35. Cohen-Kerem R., Koren G. Antioxidants and fetal protection against ethanol teratogenicity. I. Review of the experimental data and implications to humans. Neurotoxicol Teratol 2003, 25(1):1-9.
36. Marino M.D., Aksenov M.Y., Kelly S.J. Vitamin E protects against alcohol-induced cell loss and oxidative stress in the neonatal rat hippocampus. Int J Dev Neurosci 2004, 22(5-6):363-377.
37. Dong J., Sulik K.K., Chen S.Y. Nrf2-mediated transcriptional induction of antioxidant response in mouse embryos exposed to ethanol in vivo: implications for the prevention of fetal alcohol spectrum disorders. Antioxid Redox Signal 2008, 10(12):2023-2033.
38. McCarty M.F. Clinical potential of Spirulina as a source of phycocyanobilin. J Med Food 2007, 10(4):566-570.
39. Gomes A.S., Gadelha G.G., Lima S.J., Garcia J.A., Medeiros J.V., Havt A., et al. Gastroprotective effect of heme-oxygenase 1/biliverdin/CO pathway in ethanol-induced gastric damage in mice. Eur J Pharmacol 2010, 642(1-3):140-145.
40. Liu L.G., Yan H., Zhang W., Yao P., Zhang X.P., Sun X.F., et al. Induction of heme oxygenase-1 in human hepatocytes to protect them from ethanol-induced cytotoxicity. Biomed Environ Sci 2004, 17(3):315-326.
41. Yao P., Nussler A., Liu L., Hao L., Song F., Schirmeier A., et al. Quercetin protects human hepatocytes from ethanol-derived oxidative stress by inducing heme oxygenase-1 via the MAPK/Nrf2 pathways. J Hepatol 2007, 47(2):253-261.
42. Mandal P., Pritchard M.T., Nagy L.E. Anti-inflammatory pathways and alcoholic liver disease: role of an adiponectin/interleukin-10/heme oxygenase-1 pathway. World J Gastroenterol 2010, 16(11):1330-1336.
43. Atkuri K.R., Mantovani J.J., Herzenberg L.A., Herzenberg L.A. N-Acetylcysteine-a safe antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol 2007, 7(4):355-359.
44. Dodd S., Dean O., Copolov D.L., Malhi G.S., Berk M. N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility. Expert Opin Biol Ther 2008, 8(12):1955-1962.
45. Henagan J.M., Smith G.S., Schmidt K.L., Miller T.A. N-acetyl-cysteine and prostaglandin. Comparable protection against experimental ethanol injury in the stomach independent of mucus thickness. Ann Surg 1986, 204(6):698-704.
46. Vasdev S., Mian T., Longerich L., Prabhakaran V., Parai S. N-acetyl cysteine attenuates ethanol induced hypertension in rats. Artery 1995, 21(6):312-316.
47. Bosch-Morell F., Martinez-Soriano F., Colell A., Fernandez-Checa J.C., Romero F.J. Chronic ethanol feeding induces cellular antioxidants decrease and oxidative stress in rat peripheral nerves. Effect of S-adenosyl-l-methionine and N-acetyl-l-cysteine. Free Radic Biol Med 1998, 25(3):365-368.
48. Ozaras R., Tahan V., Aydin S., Uzun H., Kaya S., Senturk H. N-acetylcysteine attenuates alcohol-induced oxidative stess in rats. World J Gastroenterol 2003, 9(4):791-794.
49. Varma P.S., Aruna K., Rukkumani R., Menon V.P. Alcohol and thermally oxidized pufa induced oxidative stress: role of N-acetyl cysteine. Ital J Biochem 2004, 53(1):10-15.
50. Ronis M.J., Butura A., Sampey B.P., Shankar K., Prior R.L., Korourian S., et al. Effects of N-acetylcysteine on ethanol-induced hepatotoxicity in rats fed via total enteral nutrition. Free Radic Biol Med 2005, 39(5):619-630.
51. Ferreira Seiva F.R., Amauchi J.F., Ribeiro Rocha K.K., Souza G.A., Ebaid G.X., Burneiko R.M., et al. Effects of N-acetylcysteine on alcohol abstinence and alcohol-induced adverse effects in rats. Alcohol 2009, 43(2):127-135.
52. Tang S.M., Gabelaia L., Gauthier T.W., Brown L.A. N-acetylcysteine improves group B streptococcus clearance in a rat model of chronic ethanol ingestion. Alcohol Clin Exp Res 2009, 33(7):1197-1201.
53. Seiva F.R., Amauchi J.F., Rocha K.K., Ebaid G.X., Souza G., Fernandes A.A., et al. Alcoholism and alcohol abstinence. N-acetylcysteine to improve energy expenditure, myocardial oxidative stress, and energy metabolism in alcoholic heart disease. Alcohol 2009, 43(8):649-656.
54. Parnell S.E., Sulik K.K., Dehart D.B., Chen S.Y. Reduction of ethanol-induced ocular abnormalities in mice through dietary administration of N-acetylcysteine. Alcohol 2010, 44(7-8):699-705.
55. Surh Y.J., Kundu J.K., Na H.K. Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Med 2008, 74(13):1526-1539.
56. Flier J., Van Muiswinkel F.L., Jongenelen C.A., Drukarch B. The neuroprotective antioxidant alpha-lipoic acid induces detoxication enzymes in cultured astroglial cells. Free Radic Res 2002, 36(6):695-699.
57. Cao Z., Tsang M., Zhao H., Li Y. Induction of endogenous antioxidants and phase 2 enzymes by alpha-lipoic acid in rat cardiac H9C2 cells: protection against oxidative injury. Biochem Biophys Res Commun 2003, 310(3):979-985.
58. Gutierrez-Cabano C.A., Valenti J.L. Thioctic acid protection against ethanol and indomethacin induced gastric mucosal lesions in rats. Acta Gastroenterol Latinoam 1996, 26(3):167-171.
59. Sehirli O., Tatlidede E., Yuksel M., Erzik C., Cetinel S., Yegen B.C., et al. Antioxidant effect of alpha-lipoic acid against ethanol-induced gastric mucosal erosion in rats. Pharmacology 2008, 81(2):173-180.
60. Shirpoor A., Minassian S., Salami S., Khadem-Ansari M.H., Yeghiazaryan M. Alpha-lipoic acid decreases DNA damage and oxidative stress induced by alcohol in the developing hippocampus and cerebellum of rat. Cell Physiol Biochem 2008, 22(5-6):769-776.
61. Rodriguez C., Mayo J.C., Sainz R.M., Antolin I., Herrera F., Martin V., et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004, 36(1):1-9.
62. Melchiorri D., Sewerynek E., Reiter R.J., Ortiz G.G., Poeggeler B., Nistico G. Suppressive effect of melatonin administration on ethanol-induced gastroduodenal injury in rats in vivo. Br J Pharmacol 1997, 121(2):264-270.
63. Genc S., Gurdol F., Oner-Iyidogan Y., Onaran I. The effect of melatonin administration on ethanol-induced lipid peroxidation in rats. Pharmacol Res 1998, 37(1):37-40.
64. El-Sokkary G.H., Reiter R.J., Tan D.X., Kim S.J., Cabrera J. Inhibitory effect of melatonin on products of lipid peroxidation resulting from chronic ethanol administration. Alcohol Alcohol 1999, 34(6):842-850.
65. Bilici D., Suleyman H., Banoglu Z.N., Kiziltunc A., Avci B., Ciftcioglu A., et al. Melatonin prevents ethanol-induced gastric mucosal damage possibly due to its antioxidant effect. Dig Dis Sci 2002, 47(4):856-861.
66. Gonenc S., Uysal N., Acikgoz O., Kayatekin B.M., Sonmez A., Kiray M., et al. Effects of melatonin on oxidative stress and spatial memory impairment induced by acute ethanol treatment in rats. Physiol Res 2005, 54(3):341-348.
67. Hu S., Yin S., Jiang X., Huang D., Shen G. Melatonin protects against alcoholic liver injury by attenuating oxidative stress, inflammatory response, and apoptosis. Eur J Pharmacol 2009, 616(1-3):287-292.
68. Sonmez M.F., Narin F., Balcioglu E. Melatonin and vitamin C attenuates alcohol-induced oxidative stress in aorta. Basic Clin Pharmacol Toxicol 2009, 105(6):410-415.
69. Edwards R.B., Manzana E.J., Chen W.J. Melatonin (an antioxidant) does not ameliorate alcohol-induced Purkinje cell loss in the developing cerebellum. Alcohol Clin Exp Res 2002, 26(7):1003-1009.
70. Kim J.H., Choi S.K., Choi S.Y., Kim H.K., Chang H.I. Suppressive effect of astaxanthin isolated from the Xanthophyllomyces dendrorhous mutant on ethanol-induced gastric mucosal injury in rats. Biosci Biotechnol Biochem 2005, 69(7):1300-1305.
71. badie-Guedes R., Santos S.D., Cahu T.B., Guedes R.C., de Souza B.R. Dose-dependent effects of astaxanthin on cortical spreading depression in chronically ethanol-treated adult rats. Alcohol Clin Exp Res 2008, 32(8):1417-1421.
72. Lluis J.M., Colell A., Garcia-Ruiz C., Kaplowitz N., Fernandez-Checa J.C. Acetaldehyde impairs mitochondrial glutathione transport in HepG2 cells through endoplasmic reticulum stress. Gastroenterology 2003, 124(3):708-724.
73. Li S.Y., Ren J. Cardiac overexpression of alcohol dehydrogenase exacerbates chronic ethanol ingestion-induced myocardial dysfunction and hypertrophy: role of insulin signaling and ER stress. J Mol Cell Cardiol 2008, 44(6):992-1001.
74. Li S.Y., Gilbert S.A., Li Q., Ren J. Aldehyde dehydrogenase-2 (ALDH2) ameliorates chronic alcohol ingestion-induced myocardial insulin resistance and endoplasmic reticulum stress. J Mol Cell Cardiol 2009, 47(2):247-255.
75. Mukamal K.J., Rimm E.B. Alcohol consumption: risks and benefits. Curr Atheroscler Rep 2008, 10(6):536-543.
76. McCarty M.F. Does regular ethanol consumption promote insulin sensitivity and leanness by stimulating AMP-activated protein kinase?. Med Hypotheses 2001, 57(3):405-407.
77. Harada H., Kitazaki K., Tsujino T., Watari Y., Iwata S., Nonaka H., et al. Oral taurine supplementation prevents the development of ethanol-induced hypertension in rats. Hypertens Res 2000, 23(3):277-284.
78. Shibuya A., Yoshida A. Frequency of the atypical aldehyde dehydrogenase-2 gene (ALDH2(2)) in Japanese and Caucasians. Am J Hum Genet 1988, 43(5):741-743.
79. Budas G.R., Disatnik M.H., Mochly-Rosen D. Aldehyde dehydrogenase 2 in cardiac protection: a new therapeutic target?. Trends Cardiovasc Med 2009, 19(5):158-164.
80. Watanabe A., Hobara N., Kobayashi M., Nakatsukasa H., Nagashima H. Lowering of blood acetaldehyde but not ethanol concentrations by pantethine following alcohol ingestion: different effects in flushing and nonflushing subjects. Alcohol Clin Exp Res 1985, 9(3):272-276.
81. Watanabe A., Hobara N., Nagashima H. Activation and inhibition of yeast aldehyde dehydrogenase activity by pantethine and its metabolites. Ann Nutr Metab 1986, 30(1):54-57.
82. Watanabe A., Hobara N., Nagashima H. Lowering of liver acetaldehyde but not ethanol concentrations by pretreatment with taurine in ethanol-loaded rats. Experientia 1985, 41(11):1421-1422.
83. Watanabe A., Hobara N., Kobayashi M. Effect of taurine on blood acetaldehyde elevation following alcohol ingestion. Res Commun Subst Abuse 1985, 247-250.
84. Kerai M.D., Waterfield C.J., Kenyon S.H., Asker D.S., Timbrell J.A. Reversal of ethanol-induced hepatic steatosis and lipid peroxidation by taurine: a study in rats. Alcohol Alcohol 1999, 34(4):529-541.
85. Balkan J., Kanbagli O., Ykac-Toker G., Uysal M. Taurine treatment reduces hepatic lipids and oxidative stress in chronically ethanol-treated rats. Biol Pharm Bull 2002, 25(9):1231-1233.
86. Wu G., Yang J., Sun C., Luan X., Shi J., Hu J. Effect of taurine on alcoholic liver disease in rats. Amino Acids 2009, 36(3):457-464.
87. Devi S.L., Viswanathan P., Anuradha C.V. Taurine enhances the metabolism and detoxification of ethanol and prevents hepatic fibrosis in rats treated with iron and alcohol. Environ Toxicol Pharmacol 2009, 27(1):120-126.
88. Chen X., Sebastian B.M., Tang H., McMullen M.M., Axhemi A., Jacobsen D.W., et al. Taurine supplementation prevents ethanol-induced decrease in serum adiponectin and reduces hepatic steatosis in rats. Hepatology 2009, 49(5):1554-1562.
89. Chen S.W., Chen Y.X., Shi J., Lin Y., Xie W.F. The restorative effect of taurine on experimental nonalcoholic steatohepatitis. Dig Dis Sci 2006, 51(12):2225-2234.
90. Chang Y.Y., Chou C.H., Chiu C.H., Yang K.T., Lin Y.L., Weng W.L., et al. Preventive effects of taurine on development of hepatic steatosis induced by a high-fat/cholesterol dietary habit. J Agric Food Chem 2011, 59(1):450-457.
91. Gentile C.L., Nivala A.M., Gonzales J.C., Pfaffenbach K.T., Wang D., Wei Y., et al. Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease. Am J Physiol Regul Integr Comp Physiol 2011, 301(6):R1710-R1722.
92. Yamori Y., Taguchi T., Hamada A., Kunimasa K., Mori H., Mori M. Taurine in health and diseases: consistent evidence from experimental and epidemiological studies. J Biomed Sci 2010, 17(Suppl 1):S6.
93. McCarty M.F. Rationale for a novel nutraceutical complex 'K-water': potassium taurine bicarbonate (PTB). Med Hypotheses 2006, 67(1):65-70.
94. Xu Y.J., Arneja A.S., Tappia P.S., Dhalla N.S. The potential health benefits of taurine in cardiovascular disease. Exp Clin Cardiol 2008, 13(2):57-65.
95. Wojcik O.P., Koenig K.L., Zeleniuch-Jacquotte A., Costa M., Chen Y. The potential protective effects of taurine on coronary heart disease. Atherosclerosis 2010, 208(1):19-25.
96. Militante J.D., Lombardini J.B. Treatment of hypertension with oral taurine: experimental and clinical studies. Amino Acids 2002, 23(4):381-393.
97. Hayes K.C., Pronczuk A., Addesa A.E., Stephan Z.F. Taurine modulates platelet aggregation in cats and humans. Am J Clin Nutr 1989, 49(6):1211-1216.
98. Franconi F., Bennardini F., Mattana A., Miceli M., Ciuti M., Mian M., et al. Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: effects of taurine supplementation. Am J Clin Nutr 1995, 61(5):1115-1119.
99. Azuma J., Sawamura A., Awata N., Ohta H., Hamaguchi T., Harada H., et al. Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial. Clin Cardiol 1985, 8(5):276-282.
100. Azuma J. Long-term effect of taurine in congestive heart failure: preliminary report. Heart failure research with taurine group. Adv Exp Med Biol 1994, 359:425-433.
101. Beyranvand M.R., Khalafi M.K., Roshan V.D., Choobineh S., Parsa S.A., Piranfar M.A. Effect of taurine supplementation on exercise capacity of patients with heart failure. J Cardiol 2011, 57(3):333-337.
102. Takihara K., Azuma J., Awata N., Ohta H., Hamaguchi T., Sawamura A., et al. Beneficial effect of taurine in rabbits with chronic congestive heart failure. Am Heart J 1986, 112(6):1278-1284.
103. Wu J.Y., Prentice H. Role of taurine in the central nervous system. J Biomed Sci 2010, 17(Suppl 1):S1.
104. Yu X., Xu Z., Mi M., Xu H., Zhu J., Wei N., et al. Dietary taurine supplementation ameliorates diabetic retinopathy via anti-excitotoxicity of glutamate in streptozotocin-induced Sprague-Dawley rats. Neurochem Res 2008, 33(3):500-507.
105. El I.A., Boukarrou L., Splavnyk K., Zavyalova E., Meehan E.F., L'Amoreaux W. Functional implication of taurine in aging. Adv Exp Med Biol 2009, 643:199-206.
106. Munzel T., Daiber A., Mulsch A. Explaining the phenomenon of nitrate tolerance. Circ Res 2005, 97(7):618-628.
107. Wenzel P., Hink U., Oelze M., Schuppan S., Schaeuble K., Schildknecht S., et al. Role of reduced lipoic acid in the redox regulation of mitochondrial aldehyde dehydrogenase (ALDH-2) activity. Implications for mitochondrial oxidative stress and nitrate tolerance. J Biol Chem 2007, 282(1):792-799.
108. Dudek M., Bednarski M., Bilska A., Iciek M., Sokolowska-Jezewicz M., Filipek B., et al. The role of lipoic acid in prevention of nitroglycerin tolerance. Eur J Pharmacol 2008, 591(1-3):203-210.
109. Wenzel P., Schulz E., Gori T., Ostad M.A., Mathner F., Schildknecht S., et al. Monitoring white blood cell mitochondrial aldehyde dehydrogenase activity: implications for nitrate therapy in humans. J Pharmacol Exp Ther 2009, 330(1):63-71.
110. Gutierrez-Cabano C.A. Thioctic acid protection against ethanol-induced gastric mucosal lesions involves sulfhydryl and prostaglandin participation. Acta Gastroenterol Latinoam 1997, 27(1):31-37.
111. Bustamante J., Lodge J.K., Marcocci L., Tritschler H.J., Packer L., Rihn B.H. Alpha-lipoic acid in liver metabolism and disease. Free Radic Biol Med 1998, 24(6):1023-1039.
112. Wenzel P., Muller J., Zurmeyer S., Schuhmacher S., Schulz E., Oelze M., et al. ALDH-2 deficiency increases cardiovascular oxidative stress-evidence for indirect antioxidative properties. Biochem Biophys Res Commun 2008, 367(1):137-143.
113. Chen C.H., Budas G.R., Churchill E.N., Disatnik M.H., Hurley T.D., Mochly-Rosen D. Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science 2008, 321(5895):1493-1495.
114. Budas G.R., Disatnik M.H., Chen C.H., Mochly-Rosen D. Activation of aldehyde dehydrogenase 2 (ALDH2) confers cardioprotection in protein kinase C epsilon (PKCvarepsilon) knockout mice. J Mol Cell Cardiol 2010, 48(4):757-764.
115. Pope A.J., Druhan L., Guzman J.E., Forbes S.P., Murugesan V., Lu D., et al. Role of DDAH-1 in lipid peroxidation product-mediated inhibition of endothelial NO generation. Am J Physiol Cell Physiol 2007, 293(5):C1679-C1686.
116. Forbes S.P., Druhan L.J., Guzman J.E., Parinandi N., Zhang L., Green-Church K.B., et al. Mechanism of 4-HNE mediated inhibition of hDDAH-1: implications in no regulation. Biochemistry 2008, 47(6):1819-1826.
117. Zhang G.G., Shi R.Z., Jiang D.J., Chen Y.R., Jia C., Tang Z.Y., et al. Involvement of the endothelial DDAH/ADMA pathway in nitroglycerin tolerance: the role of ALDH-2. Life Sci 2008, 82(13-14):699-707.
118. Chang J.W., Lee E.K., Kim T.H., Min W.K., Chun S., Lee K.U., et al. Effects of alpha-lipoic acid on the plasma levels of asymmetric dimethylarginine in diabetic end-stage renal disease patients on hemodialysis: a pilot study. Am J Nephrol 2007, 27(1):70-74.
119. Mittermayer F., Pleiner J., Francesconi M., Wolzt M. Treatment with alpha-lipoic acid reduces asymmetric dimethylarginine in patients with type 2 diabetes mellitus. Transl Res 2010, 155(1):6-9.
120. Tan B., Jiang D.J., Huang H., Jia S.J., Jiang J.L., Hu C.P., et al. Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway. Vasc Pharmacol 2007, 46(5):338-345.
121. Panigrahi M., Sadguna Y., Shivakumar B.R., Kolluri S.V., Roy S., Packer L., et al. Alpha-lipoic acid protects against reperfusion injury following cerebral ischemia in rats. Brain Res 1996, 717(1-2):184-188.
122. Freisleben H.J. Lipoic acid reduces ischemia-reperfusion injury in animal models. Toxicology 2000, 148(2-3):159-171.
123. Chidlow G., Schmidt K.G., Wood J.P., Melena J., Osborne N.N. Alpha-lipoic acid protects the retina against ischemia-reperfusion. Neuropharmacology 2002, 43(6):1015-1025.
124. Sehirli O., Sener E., Cetinel S., Yuksel M., Gedik N., Sener G. Alpha-lipoic acid protects against renal ischaemia-reperfusion injury in rats. Clin Exp Pharmacol Physiol 2008, 35(3):249-255.
125. Shaafi S., Afrooz M.R., Hajipour B., Dadadshi A., Hosseinian M.M., Khodadadi A. Anti-oxidative effect of lipoic acid in spinal cord ischemia/reperfusion. Med Princ Pract 2011, 20(1):19-22.
126. He L., Liu B., Dai Z., Zhang H.F., Zhang Y.S., Luo X.J., et al. Alpha lipoic acid protects heart against myocardial ischemia-reperfusion injury through a mechanism involving aldehyde dehydrogenase 2 activation. Eur J Pharmacol 2012, 678(1-3):32-38.
127. Guz G., Oz E., Lortlar N., Ulusu N.N., Nurlu N., Demirogullari B., et al. The effect of taurine on renal ischemia/reperfusion injury. Amino Acids 2007, 32(3):405-411.
128. Tong L., Li J., Qiao H., Jiang H., Meng F., Sun X. Taurine protects against ischemia-reperfusion injury in rabbit livers. Transplant Proc 2006, 38(5):1575-1579.
129. Ueno T., Iguro Y., Yotsumoto G., Fukumoto Y., Nakamura K., Miyamoto T.A., et al. Taurine at early reperfusion significantly reduces myocardial damage and preserves cardiac function in the isolated rat heart. Resuscitation 2007, 73(2):287-295.
130. Wei S.M., Yan Z.Z., Zhou J. Beneficial effect of taurine on testicular ischemia-reperfusion injury in rats. Urology 2007, 70(6):1237-1242.
131. Sun M., Gu Y., Zhao Y., Xu C. Protective functions of taurine against experimental stroke through depressing mitochondria-mediated cell death in rats. Amino Acids 2011, 40(5):1419-1429.
132. Akdemir O., Hede Y., Zhang F., Lineaweaver W.C., Arslan Z., Songur E. Effects of taurine on reperfusion injury. J Plast Reconstr Aesthet Surg 2011, 64(7):921-928.
133. Wall T.L., Horn S.M., Johnson M.L., Smith T.L., Carr L.G. Hangover symptoms in Asian Americans with variations in the aldehyde dehydrogenase (ALDH2) gene. J Stud Alcohol 2000, 61(1):13-17.
134. Yokoyama M., Yokoyama A., Yokoyama T., Funazu K., Hamana G., Kondo S., et al. Hangover susceptibility in relation to aldehyde dehydrogenase-2 genotype, alcohol flushing, and mean corpuscular volume in Japanese workers. Alcohol Clin Exp Res 2005, 29(7):1165-1171.
135. Penning R., Van N.M., Fliervoet L.A., Olivier B., Verster J.C. The pathology of alcohol hangover. Curr Drug Abuse Rev 2010, 3(2):68-75.
136. Pittler M.H., Verster J.C., Ernst E. Interventions for preventing or treating alcohol hangover: systematic review of randomised controlled trials. BMJ 2005, 331(7531):1515-1518.
137. Facchini F., Chen Y.D., Reaven G.M. Light-to-moderate alcohol intake is associated with enhanced insulin sensitivity. Diabetes Care 1994, 17(2):115-119.
138. Kiechl S., Willeit J., Poewe W., Egger G., Oberhollenzer F., Muggeo M., et al. Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study). BMJ 1996, 313(7064):1040-1044.
139. Lazarus R., Sparrow D., Weiss S.T. Alcohol intake and insulin levels. The normative aging study. Am J Epidemiol 1997, 145(10):909-916.
140. Krenz M., Korthuis R.J. Moderate ethanol ingestion and cardiovascular protection: from epidemiologic associations to cellular mechanisms. J Mol Cell Cardiol 2012, 52(1):93-104.
141. Patra J., Taylor B., Irving H., Roerecke M., Baliunas D., Mohapatra S., et al. Alcohol consumption and the risk of morbidity and mortality for different stroke types-a systematic review and meta-analysis. BMC Public Health 2010, 10:258.
142. Baliunas D.O., Taylor B.J., Irving H., Roerecke M., Patra J., Mohapatra S., et al. Alcohol as a risk factor for type 2 diabetes: a systematic review and meta-analysis. Diabetes Care 2009, 32(11):2123-2132.
143. Anstey K.J., Mack H.A., Cherbuin N. Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies. Am J Geriatr Psychiatry 2009, 17(7):542-555.
144. Fuller T.D. Moderate alcohol consumption and the risk of mortality. Demography 2011, 48(3):1105-1125.
145. Rostron B. Alcohol consumption and mortality risks in the USA. Alcohol 2012, (2).
146. Holahan C.J., Schutte K.K., Brennan P.L., Holahan C.K., Moos B.S., Moos R.H. Late-life alcohol consumption and 20-year mortality. Alcohol Clin Exp Res 2010, 34(11):1961-1971.
147. Costanzo S., Di C.A., Donati M.B., Iacoviello L., De G.G. Alcohol consumption and mortality in patients with cardiovascular disease: a meta-analysis. J Am Coll Cardiol 2010, 55(13):1339-1347.
148. Diem P., Deplazes M., Fajfr R., Bearth A., Muller B., Christ E.R., et al. Effects of alcohol consumption on mortality in patients with type 2 diabetes mellitus. Diabetologia 2003, 46(11):1581-1585.
149. McCarty M.F. The insulin-sensitizing activity of moderate alcohol consumption may promote leanness in women. Med Hypotheses 2000, 54(5):794-797.
150. Wang L., Lee I.M., Manson J.E., Buring J.E., Sesso H.D. Alcohol consumption, weight gain, and risk of becoming overweight in middle-aged and older women. Arch Intern Med 2010, 170(5):453-461.
151. Collins M.A., Neafsey E.J., Mukamal K.J., Gray M.O., Parks D.A., Das D.K., et al. Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies. Alcohol Clin Exp Res 2009, 33(2):206-219.
152. Kondo T., Kishi M., Fushimi T., Kaga T. Acetic acid upregulates the expression of genes for fatty acid oxidation enzymes in liver to suppress body fat accumulation. J Agric Food Chem 2009, 57(13):5982-5986.
153. Sakakibara S., Yamauchi T., Oshima Y., Tsukamoto Y., Kadowaki T. Acetic acid activates hepatic AMPK and reduces hyperglycemia in diabetic KK-A(y) mice. Biochem Biophys Res Commun 2006, 344(2):597-604.
154. Sakakibara S., Murakami R., Takahashi M., Fushimi T., Murohara T., Kishi M., et al. Vinegar intake enhances flow-mediated vasodilatation via upregulation of endothelial nitric oxide synthase activity. Biosci Biotechnol Biochem 2010, 74(5):1055-1061.
155. Fernandez del M.R., Wid-Milner S., az-Calavia J.E. Pharmacology of acute alcoholic intoxication. Rev Esp Fisiol 1989, 45(Suppl):337-346.
156. Lovinger D.M., White G., Weight F.F. Ethanol inhibition of neuronal glutamate receptor function. Ann Med 1990, 22(4):247-252.
157. Siggins G.R., Roberto M., Nie Z. The tipsy terminal: presynaptic effects of ethanol. Pharmacol Ther 2005, 107(1):80-98.